REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Om Pharmaceuticals Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Om Pharmaceuticals Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

OM Pharmaceutical Industries specializes in manufacturing and researching Active Pharmaceutical Ingredients and intermediates. It supplies its products to over 30 countries and provides APIs and Intermediates to formulators in regulated and semi-regulated markets.

Legal Address
202, Vishwa Nanak Apartments Gurunanak Wadi, Chakala, Andheri (East)
Mumbai; Maharashtra; Postal Code: 400099

Contact Details: Purchase the Om Pharmaceuticals Limited report to view the information.

Basic Information
Total Employees:
Purchase the Om Pharmaceuticals Limited report to view the information.
Outstanding Shares:
Purchase the Om Pharmaceuticals Limited report to view the information.
Registered Capital:
Purchase the Om Pharmaceuticals Limited report to view the information.
Financial Auditors:
Purchase the Om Pharmaceuticals Limited report to view the information.
Incorporation Date:
November 08, 1994
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
5.43%
Purchase this report to view the information.
5.43%
Company Performance
Financial values in the chart are available after Om Pharmaceuticals Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
8.46%▲
Total operating revenue
8.44%▲
Operating profit (EBIT)
-18.26%▼
EBITDA
-10.44%▼
Net Profit (Loss) for the Period
-19.32%▼
Total assets
13.37%▲
Total equity
13.91%▲
Operating Profit Margin (ROS)
-2.82%▼
Net Profit Margin
-2.21%▼
Return on Equity (ROE)
-5.03%▼
Debt to Equity Ratio
-1.55%▼
Quick Ratio
0.29%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo